Citation Impact
Citing Papers
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Cytochrome P450s as genes for crop improvement
2001
Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1
2000 StandoutNobel
Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis
1997
Molecular, pharmacological and functional diversity of 5-HT receptors
2002 Standout
Effects of carbamazepine on acetylcholine release and metabolism
2000
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Molecular Cloning and Biochemical Characterization of a Novel Cytochrome P450, Flavone Synthase II, that Catalyzes Direct Conversion of Flavanones to Flavones
1999
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
2012
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Psychedelics
2016 Standout
The Effects of Ginkgo biloba Extracts on the Pharmacokinetics and Pharmacodynamics of Donepezil
2004
Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors
1999
In Vitro Metabolism of Isoliquiritigenin by Human Liver Microsomes
2007
The roles of segmental and tandem gene duplication in the evolution of large gene families in Arabidopsis thaliana
2004 Standout
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
Pharmacokinetics of Haloperidol
1989
CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages
2001
Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450
2002 Standout
Simple indole alkaloids and those with a nonrearranged monoterpenoid unit
2010 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Pharmacological Modulation of Cortical Excitability Shifts Induced by Transcranial Direct Current Stimulation in Humans
2003 Standout
Interaction between purinoceptor subtypes on hippocampal serotonergic transmission using in vivo microdialysis
1999
Pharmacogenetics of Antidepressants
2011
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
2004
Click Chemistry: 1,2,3‐Triazoles as Pharmacophores
2011 Standout
The biosynthesis of shikimate metabolites
1992
Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease
2001 StandoutNobel
Biosynthesis of plant pigments: anthocyanins, betalains and carotenoids
2008 Standout
Pharmacokinetics of Haloperidol
1999
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
Herb-Drug Interactions
2005 Standout
D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes
2002
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin
1999
Zonisamide for Weight Loss in Obese Adults
2003
Cloning and Functional Expression of a Cytochrome P450 cDNA Encoding 2-Hydroxyisoflavanone Synthase Involved in Biosynthesis of the Isoflavonoid Skeleton in Licorice
1999
Appetite Suppressants, Cardiac Valve Disease and Combination Pharmacotherapy
2008
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Physiological Basis of Transcranial Direct Current Stimulation
2011 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Canthin-6-one alkaloids from Eurycoma longifolia
1994
Azole-Based Energetic Salts
2011 Standout
Evidence for Possible Involvement of 5-HT2BReceptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications
2000
Phenolics and polyphenolics in foods, beverages and spices: Antioxidant activity and health effects – A review
2015 Standout
Selection of Hybrids and Edible Citrus Species with a High Content in the Diosmin Functional Compound. Modulating Effect of Plant Growth Regulators on Contents
2001
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Classics in Chemical Neuroscience: Diazepam (Valium)
2014
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Studies on the Anxiolytic Activity of Eurycoma longifolia Jack Roots in Mice
1999
THE SHIKIMATE PATHWAY
1999 Standout
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Flavonoid Biosynthesis. A Colorful Model for Genetics, Biochemistry, Cell Biology, and Biotechnology
2001 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Hallucinogens
2004 Standout
Pharmacological significance of triazole scaffold
2010
Works of K. Otani being referenced
A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine
2002
Trazodone treatment increases plasma prolactin concentrations in depressed patients
1995
Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity
2005
Effects of Carbamazepine Coadministration on Plasma Concentrations of Trazodone and Its Active Metabolite, m-Chlorophenylpiperazine
1996
Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism
2004
Inhibition of Trazodone Metabolism by Thioridazine in Humans
1995
Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ ependent dopamine release
1992
Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice
1999
Licodione Synthase, a Cytochrome P450 Monooxygenase Catalyzing 2-Hydroxylation of 5-Deoxyflavanone, in Cultured Glycyrrhiza echinata L. Cells
1994
Effects of zonisamide on dopaminergic system
1995
Effects of various factors on steady state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine
1995
Association of the TaqI A Polymorphism of the Dopamine D2 Receptor Gene With Predisposition to Neuroleptic Malignant Syndrome
2001
Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m -chlorophenylpiperazine
1997
Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines
2007
Identification of human cytochrome P450 enzymes involved in the formation of 4-hydroxyestazolam from estazolam
2005
New antiulcer quassinoids from Eurycoma longifolia
1991
Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients
1998